Douglas A Roeder has bought stock on 6 days since Feb 2018

Douglas A. Roeder is a seasoned venture capital professional and corporate director serving as an Independent Director at Senseonics Holdings, Inc. (SENS) since December 2015, following an initial term on the board from October 2011 to December 2015.( He is a Managing Partner at Delphi Ventures, Inc., a venture capital firm focused on medical devices, diagnostics, and biotechnology, where he joined as an Associate in 1998 and advanced to Partner in 2000.( Prior to Delphi, Roeder worked as an Associate in the Healthcare Investment Banking Group at Alex. Brown & Sons, contributing to numerous financings and mergers for medical technology companies.(

Roeder holds an A.B. from Dartmouth College (1993) and brings extensive board experience, currently serving at Ivantis, Inc. and previously at companies including Tandem Diabetes Care, Inc., TriVascular Technologies, Inc., and others.( As a Senseonics insider, he has actively traded SENS stock, including purchasing 325,000 shares on December 13, 2024, and owning approximately 1,413,087 shares valued over $1 million as of early 2025; his estimated net worth exceeds $37 million, largely from holdings in Tandem Diabetes Care.(

Written by Perplexity from public sources.